Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Doyle

Showing results (561-570 of 617) with videos related to

Pageof 62
Sort By:
Hepatology (Baltimore, Md.)|May 20, 2024
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective studyStanislas Pol, Alexander J Thompson, Michelle Collins, et al.
Biochemistry|September 29, 2017
First Biochemical Characterization of a Methylcitric Acid Cycle from Bacillus subtilis Strain 168Jason J Reddick, Sherona Sirkisoon, Rejwi Acharya Dahal, et al.
Medical Physics|August 5, 2020
PleThora: Pleural effusion and thoracic cavity segmentations in diseased lungs for benchmarking chest CT processing pipelinesKendall J Kiser, Sara Ahmed, Sonja Stieb, et al.
Epidemiology and Infection|March 4, 2022
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 - CORRIGENDUMAnna Lee Wilkinson, Alisa Pedrana, Michael W Traeger, et al.
Epidemiology and Infection|March 7, 2022
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019Anna Lee Wilkinson, Alisa Pedrana, Michael W Traeger, et al.
AIDS (London, England)|June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIVSamira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Nucleic Acids Research|September 5, 2013
Amplified stretch of bottlebrush-coated DNA in nanofluidic channelsCe Zhang, Armando Hernandez-Garcia, Kai Jiang, et al.
Diagnostic and Interventional Imaging|July 12, 2020
Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRIP Roca, A Attye, L Colas, et al.
Hepatology Communications|March 30, 2023
A novel point-of-care test for cirrhosis based on dimeric to monomeric IgA ratio in blood: a pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
The Lancet Regional Health. Western Pacific|January 13, 2022
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling studyDr Nick Scott, Ms Anna Palmer, Mr Tom Tidhar, et al.
Pageof 62

Showing results (561-570 of 617) with videos related to

Sort By:
Pageof 62
Hepatology (Baltimore, Md.)|May 20, 2024
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective studyStanislas Pol, Alexander J Thompson, Michelle Collins, et al.
Biochemistry|September 29, 2017
First Biochemical Characterization of a Methylcitric Acid Cycle from Bacillus subtilis Strain 168Jason J Reddick, Sherona Sirkisoon, Rejwi Acharya Dahal, et al.
Medical Physics|August 5, 2020
PleThora: Pleural effusion and thoracic cavity segmentations in diseased lungs for benchmarking chest CT processing pipelinesKendall J Kiser, Sara Ahmed, Sonja Stieb, et al.
Epidemiology and Infection|March 4, 2022
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019 - CORRIGENDUMAnna Lee Wilkinson, Alisa Pedrana, Michael W Traeger, et al.
Epidemiology and Infection|March 7, 2022
Real-world monitoring progress towards the elimination of hepatitis C virus in Australia using sentinel surveillance of primary care clinics; an ecological study of hepatitis C virus antibody tests from 2009 to 2019Anna Lee Wilkinson, Alisa Pedrana, Michael W Traeger, et al.
AIDS (London, England)|June 27, 2020
Low hepatitis C virus reinfection rate despite ongoing risk following universal access to direct-acting antiviral therapy among people living with HIVSamira Hosseini-Hooshyar, Marianne Martinello, Jasmine Yee, et al.
Nucleic Acids Research|September 5, 2013
Amplified stretch of bottlebrush-coated DNA in nanofluidic channelsCe Zhang, Armando Hernandez-Garcia, Kai Jiang, et al.
Diagnostic and Interventional Imaging|July 12, 2020
Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRIP Roca, A Attye, L Colas, et al.
Hepatology Communications|March 30, 2023
A novel point-of-care test for cirrhosis based on dimeric to monomeric IgA ratio in blood: a pilot cohort studyJessica Howell, Huy Van, Minh D Pham, et al.
The Lancet Regional Health. Western Pacific|January 13, 2022
Assessment of the cost-effectiveness of Australia's risk-sharing agreement for direct-acting antiviral treatments for hepatitis C: a modelling studyDr Nick Scott, Ms Anna Palmer, Mr Tom Tidhar, et al.
Pageof 62